Pharmacokinetics of Phenobarbital Following Single and Repeated Doses

Serum levels of phenobarbital, and also urinary excretion of phenobarbital and p-hydroxyphenobarbital, were examined after single and repeated oral doses of phenobarbital to three male subjects. Serum levels of phenobarbital at steady state were approximately ten times as high as those after a single dose. The overall elimination rate constant for loss of phenobarbital from serum, Kel, was significantly reduced after repeated doses, and Cmax infinity values calculated from single-dose data poorly predicted observed Cmax infinity values. Five-day urinary excretion of phenobarbital and p-hydroxyphenobarbital accounted for 16 and 21 per cent, respectively, of the initial dose. Due to extensive drug accumulation, 83 per cent of the final dose was excreted in five-day urine as phenobarbital and 85 per cent, as p-hydroxyphenobarbital. Comparison of plasma and renal clearances indicated that the rate of phenobarbital metabolism was reduced owing to repeated dosing, while the rate of urinary excretion of parent drug was unchanged.

[1]  P. Welling,et al.  Bioavailability of Oral and Intramuscular Phenobarbital , 1978, Journal of clinical pharmacology.

[2]  P. Welling,et al.  Interference by p-hydroxyphenobarbital in the 125I-radioimmunoassay of serum and urinary phenobarbital. , 1977, Clinical chemistry.

[3]  D. Breimer,et al.  Clinical Pharmacokinetics of Hypnotics , 1977, Clinical pharmacokinetics.

[4]  A. Dekaban,et al.  Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man. , 1977, Drug metabolism and disposition: the biological fate of chemicals.

[5]  G. Levy,et al.  Inhibition of Phenylbutazone Elimination by Its Metabolite Oxyphenbutazone , 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[6]  J. Ashley,et al.  Inhibition of diphenylhydantoin elimination by its major metabolite. , 1972, Research communications in chemical pathology and pharmacology.

[7]  C. von Bahr Binding to cytochrome P-450 and metabolism of desmethylimipramine and metabolites in rat liver microsomes. , 1970, Acta pharmacologica et toxicologica.

[8]  A. Conney Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.